share_log
Moomoo 24/7 ·  Apr 12 09:54
Adaptimmune Therapeutics Shares Down 3.5% After Roche's Genentech Terminates Deal With Co to Develop Cancer Therapies
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment